Education
About Us
Working with TipRanks
Follow Us
Pontifax Management 4 G.P. (2015) Ltd. Insider Profile
4 Followers
Pontifax Management 4 G.P. (2015) Ltd., Ten Percent Owner at Eloxx Pharmaceuticals, holds 10.50K shares in Keros Therapeutics (Ticker: KROS), holds 1.41M shares in LB Pharmaceuticals, Inc. (Ticker: LBRX), holds 616.59K shares in Eloxx Pharmaceuticals (Ticker: ELOX). Most recently, Pontifax Management 4 G.P. (2015) Ltd. Sold ― shares of Keros Therapeutics on Oct 17, 2025 for an estimated value of $84.98M.
Pontifax Management 4 G.P. (2015) Ltd. Eloxx Pharmaceuticals (ELOX)Ten Percent Owner
Eloxx Pharmaceuticals (ELOX)
Ten Percent Owner
Ranked #32,170 out of 104,058 Corporate Insiders
Profitable Transactions
2 out of 8 Profitable Transactions
Average Return
+4.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Pontifax Management 4 G.P. (2015) Ltd. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 13, 2020 - Apr 13, 2021
Return:+175.70%
The most profitable trade made by Pontifax Management 4 G.P. (2015) Ltd.
Pontifax Management 4 G.P. (2015) Ltd.'s Trading History
Eloxx Pharmaceuticals
May 17, 2021
Ten Percent Owner
Informative Buy
8.00M
$462.44K
Keros Therapeutics
Oct 17, 2025
Ten Percent Owner
Informative Sell
84.98M
$145.22K
LB Pharmaceuticals, Inc.
Sep 16, 2025
Ten Percent Owner
Informative Buy
15.00M
$22.02M
List of latest transactions for each holding click on a transaction to see Pontifax Management 4 G.P. (2015) Ltd.'s performance on stock
You May Also Like
Pontifax Management 4 G.P. (2015) Ltd. insider profile FAQ
What is the percentage of profitable transactions made by Pontifax Management 4 G.P. (2015) Ltd.?
The percentage of profitable transactions made by Pontifax Management 4 G.P. (2015) Ltd. is 25%.
What is the average return per transaction made by Pontifax Management 4 G.P. (2015) Ltd.?
The average return per transaction made by Pontifax Management 4 G.P. (2015) Ltd. is 4.00%.
What stocks does Pontifax Management 4 G.P. (2015) Ltd. hold?
Pontifax Management 4 G.P. (2015) Ltd. holds: ELOX, KROS, LBRX stocks.
What was Pontifax Management 4 G.P. (2015) Ltd.’s latest transaction?
Pontifax Management 4 G.P. (2015) Ltd. latest transaction was an Informative Sell of $84.98M.
What was Pontifax Management 4 G.P. (2015) Ltd.'s most profitable transaction?
Pontifax Management 4 G.P. (2015) Ltd.’s most profitable transaction was an Informative Buy of KROS stock on April 13, 2020. The return on the trade was 175.70%.
What is Pontifax Management 4 G.P. (2015) Ltd.'s role in Eloxx Pharmaceuticals?
Pontifax Management 4 G.P. (2015) Ltd.'s role in Eloxx Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.